Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products. One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic
Hologic will occupy two booths at this year's RSNA meeting to showcase the company's changing identity and its growing array of imaging products.
One booth will feature only new technologies from each of the company's four divisions: Hologic Radiographic Systems, which focuses on direct and general radiography; Lorad, specializing in digital and analog breast imaging and minimally invasive breast biopsy systems; Fluoroscan, which provides C-arm imaging devices for orthopedics and pain management; and Hologic Bone Densitometry Systems.
A second booth will feature a mix of new technologies and product lines from the four divisions.
Hologic and its divisions will display:
Hologic was established in 1986 as a developer, manufacturer, and marketer of proprietary x-ray and ultrasound bone analyzer systems. It is shifting focus in the hope it will become a leading provider of comprehensive radiographic solutions. If recent moves are any indication, that goal may not be unrealistic.
Hologic acquired Fluoroscan Imaging Systems in 1996 and Direct Radiography Corp. (DRC) three years later. Earlier this year the company completed its hat trick by acquiring the U.S. assets of Trex Medical, including the Lorad, Continental, and Bennett x-ray product lines.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.